DE69419966D1 - Impstoff gegen Streptococcus suis-Infektion - Google Patents

Impstoff gegen Streptococcus suis-Infektion

Info

Publication number
DE69419966D1
DE69419966D1 DE69419966T DE69419966T DE69419966D1 DE 69419966 D1 DE69419966 D1 DE 69419966D1 DE 69419966 T DE69419966 T DE 69419966T DE 69419966 T DE69419966 T DE 69419966T DE 69419966 D1 DE69419966 D1 DE 69419966D1
Authority
DE
Germany
Prior art keywords
streptococcus suis
against streptococcus
vaccine against
suis infection
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69419966T
Other languages
English (en)
Other versions
DE69419966T2 (de
Inventor
Antonius Arnoldus Chris Jacobs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Publication of DE69419966D1 publication Critical patent/DE69419966D1/de
Application granted granted Critical
Publication of DE69419966T2 publication Critical patent/DE69419966T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/825—Bacterial vaccine for porcine species, e.g. swine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69419966T 1993-05-17 1994-05-09 Impstoff gegen Streptococcus suis-Infektion Expired - Fee Related DE69419966T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93201401 1993-05-17

Publications (2)

Publication Number Publication Date
DE69419966D1 true DE69419966D1 (de) 1999-09-16
DE69419966T2 DE69419966T2 (de) 2000-01-20

Family

ID=8213828

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69419966T Expired - Fee Related DE69419966T2 (de) 1993-05-17 1994-05-09 Impstoff gegen Streptococcus suis-Infektion

Country Status (13)

Country Link
US (1) US5612042A (de)
EP (1) EP0626452B1 (de)
JP (1) JP3578799B2 (de)
AT (1) ATE183241T1 (de)
CZ (1) CZ289302B6 (de)
DE (1) DE69419966T2 (de)
DK (1) DK0626452T3 (de)
ES (1) ES2137310T3 (de)
GR (1) GR3031698T3 (de)
HU (1) HU218154B (de)
PL (1) PL177219B1 (de)
SK (1) SK281324B6 (de)
TW (1) TW494103B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI93733C (fi) * 1993-01-29 1995-05-26 Kaarina Tikkanen Streptococcus suis-bakteerin adhesiiniproteiini ja menetelmä sen valmistamiseksi
US5919466A (en) * 1993-10-01 1999-07-06 Gerbu Biotechnik Gmbh Method for improving the yield of immunoantibodies in the vaccination of animals and humans
US5863543A (en) * 1996-06-05 1999-01-26 University Of Saskatchewan Camp factor of streptococcus uberis
US6936259B2 (en) 1995-06-08 2005-08-30 University Of Saskatchewan CAMP factor of Streptococcus uberis
DK0832239T3 (da) * 1995-06-08 2006-07-31 Univ Saskatchewan CAMP faktor af streptococcus uberis
ZA97452B (en) * 1996-01-25 1997-08-15 Trinity College Dublin Streptococcus equi vaccine.
AU769539B2 (en) 1999-01-29 2004-01-29 Zoetis Services Llc Adjuvants for use in vaccines
FR2791895B1 (fr) * 1999-03-23 2001-06-15 Pasteur Merieux Serums Vacc Utilisation de trehalose pour stabiliser un vaccin liquide
MXPA03003690A (es) * 2000-10-27 2004-05-05 Chiron Spa Acidos nucleicos y proteinas de los grupos a y b de estreptococos.
NO318426B1 (no) 2001-10-02 2005-04-18 Neurozym Biotech As Et materiale for a senke konsentrasjonen av patogene tarmpeptider
DE10239629A1 (de) * 2002-08-23 2004-04-08 Idt Impfstoffwerk Dessau-Tornau Gmbh Nicht-rekombinate Subunit-Vakzine gegen Streptococcus suis-Infektionen des Schweines
ES2545265T3 (es) * 2006-03-30 2015-09-09 Zoetis Services Llc Procedimientos y composiciones de vacunación de aves de corral
US7572457B2 (en) * 2006-03-31 2009-08-11 Wisconsin Alumni Research Foundation Use of Streptococcus suis 38 kDa polypeptide as an immunogen
JP5339243B2 (ja) * 2008-04-24 2013-11-13 株式会社微生物化学研究所 ストレプトコッカス・スイス感染症予防用ワクチン
TW201043242A (en) * 2009-03-26 2010-12-16 Intervet Int Bv Vaccine for protection against Streptococcus suis bacteria of various serotypes
WO2017005913A1 (en) * 2015-07-09 2017-01-12 Intervacc Ab Vaccine against s.suis infection
US20180271969A1 (en) * 2015-10-07 2018-09-27 Boehringer Ingelheim Vetmedica, Inc. Streptococcus suis polysaccharide-protein conjugate composition
GB201703529D0 (en) * 2017-03-06 2017-04-19 Cambridge Entpr Ltd Vaccine composition
CN113957057B (zh) * 2021-11-16 2023-10-20 西南大学 一种杂交瘤细胞、能中和猪溶素的单克隆抗体及检测试剂盒

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059419A (en) * 1988-06-09 1991-10-22 Grand Laboratories, Inc. Streptococcus suis antiserum and its use in treating Streptococcus suis infections

Also Published As

Publication number Publication date
CZ289302B6 (cs) 2001-12-12
EP0626452B1 (de) 1999-08-11
EP0626452A1 (de) 1994-11-30
JP3578799B2 (ja) 2004-10-20
PL303482A1 (en) 1994-12-12
CZ117594A3 (en) 1995-02-15
SK56394A3 (en) 1995-07-11
PL177219B1 (pl) 1999-10-29
HU218154B (hu) 2000-06-28
TW494103B (en) 2002-07-11
GR3031698T3 (en) 2000-02-29
ES2137310T3 (es) 1999-12-16
HU9401511D0 (en) 1994-08-29
DE69419966T2 (de) 2000-01-20
JPH0710774A (ja) 1995-01-13
SK281324B6 (sk) 2001-02-12
ATE183241T1 (de) 1999-08-15
HUT69796A (en) 1995-09-28
DK0626452T3 (da) 2000-02-14
US5612042A (en) 1997-03-18

Similar Documents

Publication Publication Date Title
DE69419966D1 (de) Impstoff gegen Streptococcus suis-Infektion
EP1712628A3 (de) Verbindungen und Verfahren zur Immuntherapie und Diagnose von Tuberkulose
DK0733069T3 (da) Oprensede Primat CTLA-8-antigener og beslægtede reagenser
HK1080506A1 (en) Fusion proteins of mycobacterium tuberculosis
WO1999042588A3 (en) Group b streptococcus antigens
DK0807178T3 (da) Mycobaktielle proteiner, mikroorganismer producerende samme og anvendelser af nævnte proteiner i vacciner og til påvisning af tuberkulose
CA2105057A1 (en) Dna sequences which code for virulence characteristics of streptococcus suis and part thereof polypeptides and antibodies derived therefrom and the use thereof for the diagnosis of and protection against infection by s. suis in mammals, including man
TW275632B (de)
EA200100700A1 (ru) Гены и белки и их применение
DE69524971T2 (de) Neue familie von proteaseinhibitoren und andere biologisch aktive substanzen
AU2032988A (en) A genus-specific listeria antigen identified by monoclonal antibodies
SE9500418L (sv) Nya försvagade Pseudomonas aerugionos stammar
EA200100701A1 (ru) Белки наружной поверхности, их гены и их применение
DE69128095D1 (de) Azelluläre impfstoffe

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: INTERVET INTERNATIONAL B. V., AN BOXMEER, NL

8339 Ceased/non-payment of the annual fee